Arcutis Biotherapeutics, Inc.
ARQT
45 insider filings · Latest: Sep 16, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Aug 6 1:42 AM | Todd WatanabeDirector, Reporting Person's title: President and Chief Executive Officer | Sale | 4,375 | $26.12 | $114.3K | 717,203(D) | View → |
| Aug 3, 2026 | Aug 3 9:07 PM | Matsuda Masaru | Proposed Sale | 1,230 | $26.12 | $32.1K | — | View → |
| Aug 3, 2026 | Aug 3 9:07 PM | Todd Frank Watanabe | Proposed Sale | 4,375 | $26.12 | $114.3K | — | View → |
| Aug 3, 2026 | Aug 3 9:07 PM | Patrick Burnett | Proposed Sale | 955 | $26.12 | $24.9K | — | View → |
| Jul 15, 2026 | Jul 17 8:01 PM | Howard G. WelgusDirector | Sale | 4,730 | $26.91 | $127.3K | 37,109(D) | View → |
| Jul 15, 2026 | Jul 15 8:01 PM | Howard Welgus | Proposed Sale | 4,730 | $26.91 | $127.3K | — | View → |
| Jun 15, 2026 | Jun 18 12:47 AM | Sue-Jean LinDirector | Sale | 4,946 | $24.38 | $120.6K | 27,567(D) | View → |
| Jun 17, 2026 | Jun 18 12:40 AM | Howard G. WelgusDirector | Sale | 635 | $25.67 | $16.3K | 37,743(D) | View → |
| Jun 15, 2026 | Jun 18 12:40 AM | Howard G. WelgusDirector | Sale | 4,096 | $24.41 | $100.0K | 38,378(D) | View → |
| Jun 17, 2026 | Jun 17 8:08 PM | Howard Welgus | Proposed Sale | 635 | $25.67 | $16.3K | — | View → |
| Jun 15, 2026 | Jun 15 8:11 PM | Sue-Jean Lin | Proposed Sale | 4,946 | $24.38 | $120.6K | — | View → |
| Jun 15, 2026 | Jun 15 8:11 PM | Howard Welgus | Proposed Sale | 4,096 | $24.41 | $100.0K | — | View → |
| May 11, 2026 | May 13 11:43 PM | Latha VairavanSVP Chief Financial Officer | Sale | 435 | $21.05 | $9.2K | 85,978(D) | View → |
| May 11, 2026 | May 13 11:42 PM | Patrick BurnettReporting Person's Title: EVP, Chief Medical Officer | Sale | 222 | $21.05 | $4.7K | 120,244(D) | View → |
| May 11, 2026 | May 11 8:44 PM | Patrick Burnett | Proposed Sale | 222 | $21.05 | $4.7K | — | View → |
| May 11, 2026 | May 11 8:35 PM | Latha Vairavan | Proposed Sale | 435 | $21.05 | $9.2K | — | View → |
| May 4, 2026 | May 6 11:40 PM | Masaru MatsudaReporting Person's title: EVP, Chief Legal Officer | Sale | 8,256 | $23.31 | $192.4K | 126,689(D) | View → |
| May 4, 2026 | May 6 10:15 PM | Patrick BurnettReporting Person's Title: EVP, Chief Medical Officer | Sale | 684 | $23.61 | $16.1K | 120,466(D) | View → |
| May 4, 2026 | May 6 10:13 PM | Latha VairavanSVP Chief Financial Officer | Sale | 1,341 | $23.61 | $31.7K | 86,413(D) | View → |
| May 4, 2026 | May 6 10:06 PM | Todd WatanabeDirector, Reporting Person's title: President and Chief Executive Officer | Sale | 3,172 | $23.61 | $74.9K | 720,755(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Mar 4 1:42 AM | Masaru MatsudaReporting Person's title: EVP, Chief Legal Officer | Grant/Award | 97,000 | $26.97 | 97,000(D) | View → |
| Feb 27, 2026 | Mar 4 1:42 AM | Latha VairavanSVP Chief Financial Officer | Grant/Award | 70,000 | $26.97 | 70,000(D) | View → |
| Feb 27, 2026 | Mar 4 1:41 AM | Patrick BurnettReporting Person's title: EVP, Chief Medical Officer | Grant/Award | 77,000 | $26.97 | 77,000(D) | View → |
← Previous
Page 2 of 2